ADC Therapeutics ADCT
NYSE ADCT
$1.50 -0.02 (-1.64%)
As of: Oct 21, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) Equity Income (2023 - 2024)

Updated

ADC Therapeutics (ADCT) reported Equity Income of -$260,000 for Q3 2024, compared with -$1.41 million a year earlier.

Analysis

ADC Therapeutics (ADCT) Equity Income (2023 - 2024) Analysis & Trends

For FY2023, ADC Therapeutics posted Equity Income of -$5.97 million.

  • Per Business Quant data, the three quarters before Q3 2024 came in at -$597,000 (Q2 2024), -$687,000 (Q1 2024) and -$2.43 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -10.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 ADC Therapeutics 231.75 Mn -714.44 Mn 16.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -260,000.00
Jun 30, 2024 -597,000.00
Mar 31, 2024 -687,000.00
Sep 30, 2023 -1.41 Mn
Jun 30, 2023 -767,000.00
API Access

ADC Therapeutics Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ADCT&period=max&api_key=YOUR_API_KEY